Science Explorer Back to mapMap

Most cited papers from Immunome (United States)

What are the most cited papers from Immunome (United States)?

The most cited paper from Immunome (United States) is "Cellular conditions of weakly chelated magnesium ions strongly promote RNA stability and catalysis" (Ryota Yamagami, Jamie L. Bingaman, Erica A. Frankel et al., 2018), with 86 citations. Next come "White adipose tissue cells and the progression of cachexia: inflammatory pathways" (56) and "Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains" (22).

Showing 19 of 19 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Cellular conditions of weakly chelated magnesium ions strongly promote RNA stability and catalysis Ryota Yamagami, Jamie L. Bingaman, Erica A. Frankel et al. · Nature Communications Open access 25 May 2018 86
2 White adipose tissue cells and the progression of cachexia: inflammatory pathways Rodrigo Xavier das Neves, José Cesar Rosa Neto, Alex Shimura Yamashita et al. · Journal of Cachexia Sarcopenia and Muscle Open access 7 Jul 2015 56
3 Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains Rama Devudu Puligedda, Diana V. Kouiavskaia, Sharad P. Adekar et al. · Antiviral Research 10 May 2014 22
4 Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development Wayne Chester Koff, Rino Rappuoli, Stanley Alan Plotkin · Journal of Molecular Biology 18 Apr 2023 18
5 IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation John P. Dowling, Pavel A. Nikitin, Fang Shen et al. · mAbs Open access 22 May 2023 16
6 A consumer charter for genomic services Fred David Ledley · Nature Biotechnology Aug 2002 15
7 Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor Rashmi Sharma, Huiwu Zhao, Fetweh H. Al‐Saleem et al. · Molecular Immunology Open access Nov 2013 15
8 Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein Sharad P. Adekar, Andrew T. Segan, Cindy Si Chen et al. · PLoS ONE Open access 2 Mar 2011 14
9 IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2 Pavel A. Nikitin et al. · Science Immunology Open access 30 Jun 2022 12
10 Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein Jillian M. DiMuzio, Baron C. Heimbach, Raymond J. Howanski et al. · Vaccine X Open access 24 Apr 2021 10
11 1766P Updated results of the RINGSIDE phase II trial and open-label extension of AL102 for treatment of desmoid tumors B. Kasper, Mrinal M. Gounder, Rashmi K Chugh et al. · Annals of Oncology Open access Sep 2024 4
12 Enzymatic Pathway for Kupyaphore Degradation in Mycobacterium tuberculosis: Mechanism of Metal Homeostasis and Turnover Rashmi S. Bhosale, Arnab Kumar Chakraborty, Tsung-Yun Wong et al. · ACS Chemical Biology 30 Jun 2025 2
13 Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer Daping Zhang, Adekemi B. Taylor, Jie Janet Zhao et al. · Clinical Pharmacokinetics Open access Oct 2024 2
14 Repression of LKB1 by miR-17∼92 sensitizes MYC -dependent lymphoma to biguanide treatment Said Izreig, Alexandra Gariepy, Ariel O. Donayo et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 20 Dec 2019 2
15 Hypomorphic RAG2 Deficiency Promotes Selection of Self-Reactive B Cells Christopher D. Thouvenel et al. · Journal of Clinical Immunology Open access 15 Jan 2025 1
16 Autonomic Function Recovery in Post-Covid-19 Young Adults After Immunization: An Observational Follow up Case-control Study Ana Paula Coelho Figueira Freire, Shaan N. Amin, Fábio Santos Lira et al. · Preprints.org PreprintOpen access 28 Nov 2022 1
17 Diversification and shared features of tumor‐binding antibody repertoires in tumor, sentinel lymph node and blood of three patients with breast cancer Stephanie C. Pero, Aaron M. Rosenfeld, Girja S. Shukla et al. · Clinical & Translational Immunology Open access 2022 1
18 Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail Pavel A. Nikitin et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 19 Oct 2021 1
19 Scientific and Regulatory Policy Committee Points to Consider* for Determining and Reporting Cause of Death/Moribundity in Non-Rodent Species in Toxicity Studies Karyn A. Colman, Kathleen A. Funk, Michael Boyle et al. · Toxicologic Pathology 20 Mar 2025 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.